News
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...
Anthem Biosciences IPO Allotment status, Anthem IPO GMP Price: Anthem Biosciences IPO allotment status set to go live today after oversubscription; check your allotment now!
Ahmedabad: Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) for its massive Rs ...
Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...
Elevance Health earns a narrow moat rating from us, which is fundamentally anchored by its competitive advantages in medical insurance. Elevance's strategy centers on emphasizing its strengths in the ...
Regulatory upheaval in the US and a venture capital drought are dampening investor appetites, but there are still diamonds in ...
Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...
The company has plans to make further acquisitions to enter newer product segments and geographies and expand market share.
The pharmaceutical industry is expected to cover 57% of the additional €466 million expected for the 2026 budget, through a ...
UK inflation figures are expected to show no real change between May and June as the struggle to bring down costs continues, ...
Dubai: Share prices of Indian pharmaceutical companies – and especially those with high export volumes – are coming under investor spotlight after the latest tariff threat from US President Trump. Of ...
Vertex Pharmaceuticals (VRTX) reached $464.2 at the closing of the latest trading day, reflecting a -1.73% change compared to its last close.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results